Literature DB >> 20807474

The genetics of systemic sclerosis.

Sandeep K Agarwal1.   

Abstract

Systemic sclerosis (SSc, scleroderma) is an autoimmune disease clinically characterized by progressive fibrosis in the skin and internal organs. While the pathogenesis of SSc is not completely understood, familial studies and genetic studies suggest that SSc is a complex polygenic disease. In the current review, we will discuss recent studies investigating genetic susceptibility to SSc. Candidate gene studies have identified critical immunoregulatory genes and gene regions including BANK1, FAM167A-BLK, IL23R, IRF5, STAT4, TBX21, and TNFSF4 as susceptibility genes for the development of SSc. More recently a genome-wide association study has been performed and identified CD247 (CD3-zeta) as a novel genetic risk factor for the susceptibility to SSc. Together these genetic association studies have substantially advanced our understanding of SSc pathogenesis and form the foundation for future studies seeking to understand the complexities of SSc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807474      PMCID: PMC3803145     

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  91 in total

Review 1.  Systemic sclerosis: hypothesis-driven treatment strategies.

Authors:  Christina Charles; Philip Clements; Daniel E Furst
Journal:  Lancet       Date:  2006-05-20       Impact factor: 79.321

2.  A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.

Authors:  Robert R Graham; Sergey V Kozyrev; Emily C Baechler; M V Prasad Linga Reddy; Robert M Plenge; Jason W Bauer; Ward A Ortmann; Thearith Koeuth; Ma Francisca González Escribano; Bernardo Pons-Estel; Michelle Petri; Mark Daly; Peter K Gregersen; Javier Martín; David Altshuler; Timothy W Behrens; Marta E Alarcón-Riquelme
Journal:  Nat Genet       Date:  2006-04-16       Impact factor: 38.330

3.  A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families.

Authors:  S Onengut-Gumuscu; K G Ewens; R S Spielman; P Concannon
Journal:  Genes Immun       Date:  2004-12       Impact factor: 2.676

4.  Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982.

Authors:  V D Steen; C V Oddis; C G Conte; J Janoski; G Z Casterline; T A Medsger
Journal:  Arthritis Rheum       Date:  1997-03

5.  Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Gisela Orozco; Elena Sánchez; Miguel A González-Gay; Miguel A López-Nevot; Belén Torres; Rafael Cáliz; Norberto Ortego-Centeno; Juan Jiménez-Alonso; Dora Pascual-Salcedo; Alejandro Balsa; Rosario de Pablo; Antonio Nuñez-Roldan; Maria Francisca González-Escribano; Javier Martín
Journal:  Arthritis Rheum       Date:  2005-01

6.  Familial risk estimation in systemic sclerosis.

Authors:  H Englert; J Small-McMahon; P Chambers; H O'Connor; K Davis; N Manolios; R White; G Dracos; P Brooks
Journal:  Aust N Z J Med       Date:  1999-02

7.  Structure and developmental regulation of the B-lymphoid tyrosine kinase gene blk.

Authors:  S M Dymecki; P Zwollo; K Zeller; F P Kuhajda; S V Desiderio
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

8.  Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis.

Authors:  A Igarashi; K Nashiro; K Kikuchi; S Sato; H Ihn; G R Grotendorst; K Takehara
Journal:  J Invest Dermatol       Date:  1995-08       Impact factor: 8.551

9.  Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders.

Authors:  A Igarashi; K Nashiro; K Kikuchi; S Sato; H Ihn; M Fujimoto; G R Grotendorst; K Takehara
Journal:  J Invest Dermatol       Date:  1996-04       Impact factor: 8.551

Review 10.  Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4.

Authors:  Wendy T Watford; Bruce D Hissong; Jay H Bream; Yuka Kanno; Linda Muul; John J O'Shea
Journal:  Immunol Rev       Date:  2004-12       Impact factor: 12.988

View more
  14 in total

Review 1.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

2.  Targeting STAT4 in systemic sclerosis: a promising new direction.

Authors:  Jammie Barnes; Sandeep K Agarwal
Journal:  Expert Rev Clin Immunol       Date:  2011-07       Impact factor: 4.473

Review 3.  Kidney involvement in systemic sclerosis: From pathogenesis to treatment.

Authors:  Cosimo Bruni; Giovanna Cuomo; Francesca W Rossi; Emanuela Praino; Silvia Bellando-Randone
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

Review 4.  Genetics, Epigenetics, and Genomics of Systemic Sclerosis.

Authors:  Gloria Salazar; Maureen D Mayes
Journal:  Rheum Dis Clin North Am       Date:  2015-05-20       Impact factor: 2.670

Review 5.  Genetics of systemic sclerosis: an update.

Authors:  Jasper C A Broen; Marieke J H Coenen; Timothy R D J Radstake
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

6.  Vascular involvement in systemic sclerosis (scleroderma).

Authors:  Debendra Pattanaik; Monica Brown; Arnold E Postlethwaite
Journal:  J Inflamm Res       Date:  2011-07-26

7.  DNA methylation similarities in genes of black South Africans with systemic lupus erythematosus and systemic sclerosis.

Authors:  Puleng Matatiele; Mohamed Tikly; Gareth Tarr; Mary Gulumian
Journal:  J Biomed Sci       Date:  2015-05-20       Impact factor: 8.410

Review 8.  Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight).

Authors:  Hiroshi Furukawa; Shomi Oka; Kota Shimada; Naoyuki Tsuchiya; Shigeto Tohma
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-04-29

9.  Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01.

Authors:  Hiroshi Furukawa; Shomi Oka; Aya Kawasaki; Kota Shimada; Shoji Sugii; Takashi Matsushita; Atsushi Hashimoto; Akiko Komiya; Naoshi Fukui; Kouji Kobayashi; Atsumu Osada; Atsushi Ihata; Yuya Kondo; Tatsuo Nagai; Keigo Setoguchi; Akiko Okamoto; Akira Okamoto; Noriyuki Chiba; Eiichi Suematsu; Hajime Kono; Masao Katayama; Shunsei Hirohata; Takayuki Sumida; Kiyoshi Migita; Minoru Hasegawa; Manabu Fujimoto; Shinichi Sato; Shouhei Nagaoka; Kazuhiko Takehara; Shigeto Tohma; Naoyuki Tsuchiya
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

Review 10.  Current perspectives on the immunopathogenesis of systemic sclerosis.

Authors:  Patrizia Fuschiotti
Journal:  Immunotargets Ther       Date:  2016-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.